1. Home
  2. WST vs STX Comparison

WST vs STX Comparison

Compare WST & STX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • STX
  • Stock Information
  • Founded
  • WST 1923
  • STX 1978
  • Country
  • WST United States
  • STX Singapore
  • Employees
  • WST N/A
  • STX N/A
  • Industry
  • WST Medical/Dental Instruments
  • STX Electronic Components
  • Sector
  • WST Health Care
  • STX Technology
  • Exchange
  • WST Nasdaq
  • STX Nasdaq
  • Market Cap
  • WST 20.1B
  • STX 46.3B
  • IPO Year
  • WST N/A
  • STX 2002
  • Fundamental
  • Price
  • WST $299.62
  • STX $235.57
  • Analyst Decision
  • WST Strong Buy
  • STX Buy
  • Analyst Count
  • WST 8
  • STX 21
  • Target Price
  • WST $348.00
  • STX $222.19
  • AVG Volume (30 Days)
  • WST 707.3K
  • STX 4.8M
  • Earning Date
  • WST 10-23-2025
  • STX 10-28-2025
  • Dividend Yield
  • WST 0.30%
  • STX 1.23%
  • EPS Growth
  • WST 0.17
  • STX 328.48
  • EPS
  • WST 6.75
  • STX 6.77
  • Revenue
  • WST $3,017,900,000.00
  • STX $9,097,000,000.00
  • Revenue This Year
  • WST $6.49
  • STX $16.83
  • Revenue Next Year
  • WST $6.23
  • STX $10.88
  • P/E Ratio
  • WST $44.06
  • STX $34.58
  • Revenue Growth
  • WST 4.92
  • STX 38.86
  • 52 Week Low
  • WST $187.43
  • STX $63.19
  • 52 Week High
  • WST $352.33
  • STX $264.83
  • Technical
  • Relative Strength Index (RSI)
  • WST 72.87
  • STX 60.91
  • Support Level
  • WST $260.12
  • STX $209.00
  • Resistance Level
  • WST $322.34
  • STX $233.28
  • Average True Range (ATR)
  • WST 7.39
  • STX 10.64
  • MACD
  • WST 3.28
  • STX -1.74
  • Stochastic Oscillator
  • WST 64.97
  • STX 74.34

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About STX Seagate Technology Holdings PLC (Ireland)

Seagate Technology is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.

Share on Social Networks: